Impact of Relative Muscle Power on Hospitalization and All-Cause Mortality in Older Adults.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
01 04 2022
Historique:
received: 07 10 2020
pubmed: 19 8 2021
medline: 6 4 2022
entrez: 18 8 2021
Statut: ppublish

Résumé

The purpose of this study was to evaluate the relationship of lower-limb muscle power with mortality and hospitalization. A total of 1 928 participants from the Toledo Study for Healthy Aging were included. Muscle power was assessed with the 5-repetition sit-to-stand test and participants were classified into different groups of relative power (ie, normalized to body mass) according to sex-specific tertiles and their inability to perform the test. Mean follow-up periods for hospitalization and all-cause mortality were 3.3 and 6.3 years, respectively. Compared to the high relative muscle power group, men with low (HR [95% CI] = 2.1 [1.2-3.6]) and women with very low and low (HR [95% CI] = 4.7 [3.0-7.4] and 1.8 [1.2-2.7]) relative power had an increased age-adjusted risk of hospitalization. After adjusting for several covariates (age, physical activity, body mass index education, depression, comorbidities, disability, and handgrip strength), these effects were attenuated (men and women with very low relative power: HR [95% CI] = 1.6 [0.9-2.9] and 2.8 [1.6-4.9]). The very low relative muscle power group had also an increased all-cause mortality risk (age-adjusted) in both men and women (HR [95% CI] = 2.3 [1.4-3.9] and 2.9 [1.6-5.3]). After adjusting for all the covariates, a significantly increased mortality risk was observed only in men (HR [95% CI] = 2.1 [1.1-3.8]; women HR [95% CI] = 1.6 [0.8-3.2]), with very low levels of relative power. Relative muscle power was independently and negatively associated with mortality and hospitalization in older adults. An augmented all-cause mortality risk was noted in the lowest group of relative muscle power.

Sections du résumé

BACKGROUND
The purpose of this study was to evaluate the relationship of lower-limb muscle power with mortality and hospitalization.
METHODS
A total of 1 928 participants from the Toledo Study for Healthy Aging were included. Muscle power was assessed with the 5-repetition sit-to-stand test and participants were classified into different groups of relative power (ie, normalized to body mass) according to sex-specific tertiles and their inability to perform the test. Mean follow-up periods for hospitalization and all-cause mortality were 3.3 and 6.3 years, respectively.
RESULTS
Compared to the high relative muscle power group, men with low (HR [95% CI] = 2.1 [1.2-3.6]) and women with very low and low (HR [95% CI] = 4.7 [3.0-7.4] and 1.8 [1.2-2.7]) relative power had an increased age-adjusted risk of hospitalization. After adjusting for several covariates (age, physical activity, body mass index education, depression, comorbidities, disability, and handgrip strength), these effects were attenuated (men and women with very low relative power: HR [95% CI] = 1.6 [0.9-2.9] and 2.8 [1.6-4.9]). The very low relative muscle power group had also an increased all-cause mortality risk (age-adjusted) in both men and women (HR [95% CI] = 2.3 [1.4-3.9] and 2.9 [1.6-5.3]). After adjusting for all the covariates, a significantly increased mortality risk was observed only in men (HR [95% CI] = 2.1 [1.1-3.8]; women HR [95% CI] = 1.6 [0.8-3.2]), with very low levels of relative power.
CONCLUSIONS
Relative muscle power was independently and negatively associated with mortality and hospitalization in older adults. An augmented all-cause mortality risk was noted in the lowest group of relative muscle power.

Identifiants

pubmed: 34407184
pii: 6354429
doi: 10.1093/gerona/glab230
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

781-789

Subventions

Organisme : Biomedical Research Networking Center on Frailty and Healthy Aging
ID : RD12/0043
Organisme : Instituto de Salud Carlos III
ID : PI2010/020
Organisme : Junta de Comunidades de Castilla La Mancha
ID : FP7-305483-2
Organisme : FP7 Health 2012 Innovation

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jose Losa-Reyna (J)

Department of Geriatrics, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.
GENUD Toledo Research Group, Universidad de Castilla-La Mancha, Toledo, Spain.

Julian Alcazar (J)

CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.
GENUD Toledo Research Group, Universidad de Castilla-La Mancha, Toledo, Spain.

Jose Carnicero (J)

Department of Geriatrics, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.
Department of Geriatrics, Hospital Universitario de Getafe, Spain.

Ana Alfaro-Acha (A)

Department of Geriatrics, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.

Carmen Castillo-Gallego (C)

Department of Geriatrics, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.

Cristina Rosado-Artalejo (C)

Department of Geriatrics, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.

Leocadio Rodríguez-Mañas (L)

CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.
Department of Geriatrics, Hospital Universitario de Getafe, Spain.

Ignacio Ara (I)

CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.
GENUD Toledo Research Group, Universidad de Castilla-La Mancha, Toledo, Spain.

Francisco José García-García (FJ)

Department of Geriatrics, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH